Videos

What happens to your body in space?
When gravity disappears, the body changes in ways we’re only starting to understand — and the liver is no exception. Postdoctoral researcher Sinem Helvacıoğlu Akyüz (VUB) is studying how microgravity affects liver cells, especially the proteins responsible for moving drugs through the body. Her research could lead to better protections for astronauts — and new insights into treating disease on Earth.

Why do so many promising drugs fail in clinical trials? Often because they’re tested on flat cell cultures that don’t reflect real human biology. That's why Anubhav Bussooa (VUB) is developing 3D cell models that mimic how real tissues work — including root-like structures that deliver oxygen and nutrients to the cells at the center of these spheres. These models could lead to better, faster, and more accurate drug testing.

How did people in dry regions like Cyprus survive long periods without rain? Thousands of years ago, they built stone terraces to slow down water, allowing it to soak into the soil and nourish crops. At VUB, archaeologist Ella Egberts is combining archaeological fieldwork with scientific analysis to uncover how these systems worked — and what they can teach us about drought resilience today.
🎥 Watch the video to discover how ancient solutions can inspire a more sustainable future.

With resistant bacteria on the rise, traditional antibiotics are losing their power. Richa Scharma, (VUB), is taking a new direction. Instead of killing bacteria outright, she’s designing molecules that block their ability to cause disease.
This strategy could lead to next-generation antibiotics that are harder for bacteria to resist — helping us stay ahead in the fight against superbugs.
🎥 Watch the video to discover how Richa’s research is reshaping the fight against antibiotic resistance.

What does a fast-food diet have to do with your brain health? 🍔 🧠
Parkash Singh Rawati (VUB) is studying the link between processed food, gut bacteria, and brain inflammation. His work focuses on a gas called hydrogen sulfide (H₂S), produced by gut bacteria when we eat too many refined or processed foods. This gas may be a hidden driver of brain inflammation linked to conditions like multiple sclerosis. By comparing the gut microbiota of MS patients with healthy individuals, Parkash hopes to open the door to new treatments, from targeted probiotics to diet-based strategies for protecting brain health.